| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
Chest, Vol 91, 527-532, Copyright © 1987 by American College of Chest Physicians
ARTICLES |
OC Tablan, WJ Martone, CF Doershuk, RC Stern, MJ Thomassen, JD Klinger, JW White, LA Carson and WR Jarvis
Between 1981 and 1983, some 85 patients with cystic fibrosis at Rainbow Babies and Childrens Hospital, Cleveland, developed colonization or infection of the respiratory tract with Pseudomonas cepacia. Twenty- nine (34 percent) of the colonized patients died; four were female patients with fulminant bacteremia with P cepacia prior to death. Case- control studies showed that increasing severity of underlying cystic fibrosis, increasing age, having a sibling with cystic fibrosis who was colonized with P cepacia, and previous hospitalizations were associated with increased risk of colonization. In patients with mild cystic fibrosis, no differences in clinical outcome were seen during the period of study; however, patients colonized with P cepacia who had moderate or advanced cystic fibrosis were hospitalized longer and died sooner after colonization, compared with control subjects with similar severity of cystic fibrosis. The excess mortality associated with such colonization varied in magnitude and trend according to the patient's sex and severity of underlying cystic fibrosis, reflecting the combined influence of colonization with P cepacia, sex, and severity of cystic fibrosis on the mortality of the patients. The source and mode of transmission of P cepacia were not determined, but the data suggest a possible nosocomial source. The results of this investigation showed that colonization with P cepacia most often affected patients with moderate or advanced cystic fibrosis and was associated with an adverse clinical outcome in these patients.
This article has been cited by other articles:
|
|
 |
|
  J S Elborn Practical Management of Cystic Fibrosis Chronic Respiratory Disease, July 1, 2006; 3(3): 161 - 165. [PDF]
|
|
|
|
 |
|
 L. A. Kalish, D. A. Waltz, M. Dovey, G. Potter-Bynoe, A. J. McAdam, J. J. LiPuma, C. Gerard, and D. Goldmann Impact of Burkholderia dolosa on Lung Function and Survival in Cystic Fibrosis Am. J. Respir. Crit. Care Med., February 15, 2006; 173(4): 421 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A M Jones, M E Dodd, J R W Govan, V Barcus, C J Doherty, J Morris, and A K Webb Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis Thorax, November 1, 2004; 59(11): 948 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Rosenbluth, K. Wilson, T. Ferkol, and D. P. Schuster Lung Function Decline in Cystic Fibrosis Patients and Timing for Lung Transplantation Referral Chest, August 1, 2004; 126(2): 412 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Saiman and J. Siegel Infection Control in Cystic Fibrosis Clin. Microbiol. Rev., January 1, 2004; 17(1): 57 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Gibson, J. L. Burns, and B. W. Ramsey Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 918 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Tomich, A. Griffith, C. A. Herfst, J. L. Burns, and C. D. Mohr Attenuated Virulence of a Burkholderia cepacia Type III Secretion Mutant in a Murine Model of Infection Infect. Immun., March 1, 2003; 71(3): 1405 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Chu, D. J. Davidson, T. K. Halsey, J. W. Chung, and D. P. Speert Differential Persistence among Genomovars of the Burkholderia cepacia Complex in a Murine Model of Pulmonary Infection Infect. Immun., May 1, 2002; 70(5): 2715 - 2720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tomich, C. A. Herfst, J. W. Golden, and C. D. Mohr Role of Flagella in Host Cell Invasion by Burkholderia cepacia Infect. Immun., April 1, 2002; 70(4): 1799 - 1806. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Saiman, Y. Chen, S. Tabibi, P. San Gabriel, J. Zhou, Z. Liu, L. Lai, and S. Whittier Identification and Antimicrobial Susceptibility of Alcaligenes xylosoxidans Isolated from Patients with Cystic Fibrosis J. Clin. Microbiol., November 1, 2001; 39(11): 3942 - 3945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Lewenza and P. A. Sokol Regulation of Ornibactin Biosynthesis and N-Acyl-L-Homoserine Lactone Production by CepR in Burkholderia cepacia J. Bacteriol., April 1, 2001; 183(7): 2212 - 2218. [Abstract] [Full Text]
|
|
|
|
|
|
C. CHAPARRO, J. MAURER, C. GUTIERREZ, M. KRAJDEN, C. CHAN, T. WINTON, S. KESHAVJEE, M. SCAVUZZO, E. TULLIS, M. HUTCHEON, et al. Infection with Burkholderia cepacia in Cystic Fibrosis . Outcome Following Lung Transplantation Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 43 - 48. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. LiPuma, B. J. Dulaney, J. D. McMenamin, P. W. Whitby, T. L. Stull, T. Coenye, and P. Vandamme Development of rRNA-Based PCR Assays for Identification of Burkholderia cepacia Complex Isolates Recovered from Cystic Fibrosis Patients J. Clin. Microbiol., October 1, 1999; 37(10): 3167 - 3170. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Shreve, S. Butler, H. J. Kaplowitz, H. R. Rabin, D. Stokes, M. Light, W. E. Regelmann, and Investigators for the Epidemiologic Study of Cysti Impact of Microbiology Practice on Cumulative Prevalence of Respiratory Tract Bacteria in Patients with Cystic Fibrosis J. Clin. Microbiol., March 1, 1999; 37(3): 753 - 757. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. W. Ramsey Management of Pulmonary Disease in Patients with Cystic Fibrosis N. Engl. J. Med., July 18, 1996; 335(3): 179 - 188. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
